A class action suit is the best method for resolving multiple consumer fraud claims against a drug manufacturer over its allegedly deceptive product advertising, New Jersey’s Supreme Court held unanimously on Thursday.

The ruling allows thousands of dissatisfied users of the dietary supplement Relacore to sue collectively, overturning lower court findings that there are too many possible variables to satisfy the class action commonality requirement.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]